AI driven B-cell Immunotherapy Design

• URL: http://arxiv.org/abs/2309.01122v1
• Date: Sun, 3 Sep 2023 09:14:10 GMT
• Title: AI driven B-cell Immunotherapy Design
• Authors: Bruna Moreira da Silva (1), David B. Ascher (2), Nicholas Geard (1), Douglas E. V. Pires (1) ((1) The University of Melbourne, (2) The University of Queensland)
• Abstract summary: The effectiveness of antigen neutralisation and elimination hinges upon the strength, sensitivity, and specificity of the paratope-epitope interaction. In recent years, artificial intelligence and machine learning methods have made significant strides, revolutionising the prediction of protein structures and their complexes. This review focuses on the progress of machine learning-based tools and their frameworks in the domain of B-cell immunotherapy design.
• Score: 0.0
• License: http://creativecommons.org/licenses/by-nc-nd/4.0/
• Abstract: Antibodies, a prominent class of approved biologics, play a crucial role in detecting foreign antigens. The effectiveness of antigen neutralisation and elimination hinges upon the strength, sensitivity, and specificity of the paratope-epitope interaction, which demands resource-intensive experimental techniques for characterisation. In recent years, artificial intelligence and machine learning methods have made significant strides, revolutionising the prediction of protein structures and their complexes. The past decade has also witnessed the evolution of computational approaches aiming to support immunotherapy design. This review focuses on the progress of machine learning-based tools and their frameworks in the domain of B-cell immunotherapy design, encompassing linear and conformational epitope prediction, paratope prediction, and antibody design. We mapped the most commonly used data sources, evaluation metrics, and method availability and thoroughly assessed their significance and limitations, discussing the main challenges ahead.

Related papers

• Immunogenicity Prediction with Dual Attention Enables Vaccine Target Selection [6.949493332885247]
  ProVaccine is a novel deep learning solution that integrates latent vector representations of protein sequences and structures. We also compile the most comprehensive immunogenicity dataset to date, encompassing over 9,500 antigen sequences, structures, and immunogenicity labels from bacteria, viruses, and tumors. Our work provides an effective tool for vaccine design and sets valuable benchmarks for future research.
  arXiv  Detail & Related papers  (2024-10-03T16:33:35Z)
• BeeTLe: A Framework for Linear B-Cell Epitope Prediction and Classification [0.43512163406551996]
  This paper presents a new deep learning-based framework for linear B-cell prediction as well as antibody type-specific classification. We propose an amino acid encoding method based on eigen decomposition to help the model learn the representations of antibodies. Experimental results on data curated from the largest public database demonstrate the validity of the proposed methods.
  arXiv  Detail & Related papers  (2023-09-05T09:18:29Z)
• Adversarial Attacks and Defenses in Machine Learning-Powered Networks: A Contemporary Survey [114.17568992164303]
  Adrial attacks and defenses in machine learning and deep neural network have been gaining significant attention. This survey provides a comprehensive overview of the recent advancements in the field of adversarial attack and defense techniques. New avenues of attack are also explored, including search-based, decision-based, drop-based, and physical-world attacks.
  arXiv  Detail & Related papers  (2023-03-11T04:19:31Z)
• xTrimoABFold: De novo Antibody Structure Prediction without MSA [77.47606749555686]
  We develop a novel model named xTrimoABFold to predict antibody structure from antibody sequence. The model was trained end-to-end on the antibody structures in PDB by minimizing the ensemble loss of domain-specific focal loss on CDR and the frame-aligned point loss.
  arXiv  Detail & Related papers  (2022-11-30T09:26:08Z)
• Incorporating Pre-training Paradigm for Antibody Sequence-Structure Co-design [134.65287929316673]
  Deep learning-based computational antibody design has attracted popular attention since it automatically mines the antibody patterns from data that could be complementary to human experiences. The computational methods heavily rely on high-quality antibody structure data, which is quite limited. Fortunately, there exists a large amount of sequence data of antibodies that can help model the CDR and alleviate the reliance on structure data.
  arXiv  Detail & Related papers  (2022-10-26T15:31:36Z)
• Antibody Representation Learning for Drug Discovery [7.291511531280898]
  We present results on a novel SARS-CoV-2 antibody binding dataset and an additional benchmark dataset. We compare three classes of models: conventional statistical sequence models, supervised learning on each dataset independently, and fine-tuning an antibody specific pre-trained language model. Experimental results suggest that self-supervised pretraining of feature representation consistently offers significant improvement in over previous approaches.
  arXiv  Detail & Related papers  (2022-10-05T13:48:41Z)
• Benchmarking Heterogeneous Treatment Effect Models through the Lens of Interpretability [82.29775890542967]
  Estimating personalized effects of treatments is a complex, yet pervasive problem. Recent developments in the machine learning literature on heterogeneous treatment effect estimation gave rise to many sophisticated, but opaque, tools. We use post-hoc feature importance methods to identify features that influence the model's predictions.
  arXiv  Detail & Related papers  (2022-06-16T17:59:05Z)
• Neural message passing for joint paratope-epitope prediction [0.0]
  Antibodies are proteins in the immune system which bind to antigens to detect and neutralise them. Prediction of binding sites in an antibody-antigen interaction are known as the paratope and, respectively, and are key to vaccine and synthetic antibody development.
  arXiv  Detail & Related papers  (2021-05-31T16:37:55Z)
• Sequence-based deep learning antibody design for in silico antibody affinity maturation [0.0]
  optimization step for therapeutic leads is increasingly popular in antibody discovery pipeline. Traditional methods and in silico approaches aim to generate candidates with high binding affinity against specific target antigens. In the present study, we investigated different graph-based designs for depicting antibody-antigen interactions in terms of antibody affinity prediction.
  arXiv  Detail & Related papers  (2021-02-21T02:48:31Z)
• MIA-Prognosis: A Deep Learning Framework to Predict Therapy Response [58.0291320452122]
  This paper aims at a unified deep learning approach to predict patient prognosis and therapy response. We formalize the prognosis modeling as a multi-modal asynchronous time series classification task. Our predictive model could further stratify low-risk and high-risk patients in terms of long-term survival.
  arXiv  Detail & Related papers  (2020-10-08T15:30:17Z)
• Neuro-symbolic Neurodegenerative Disease Modeling as Probabilistic Programmed Deep Kernels [93.58854458951431]
  We present a probabilistic programmed deep kernel learning approach to personalized, predictive modeling of neurodegenerative diseases. Our analysis considers a spectrum of neural and symbolic machine learning approaches. We run evaluations on the problem of Alzheimer's disease prediction, yielding results that surpass deep learning.
  arXiv  Detail & Related papers  (2020-09-16T15:16:03Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.